CNC and FSFG made it to the Zacks Rank #1 (Strong Buy) value stocks list on May 1, 2025.
Investors interested in stocks from the Medical - HMOs sector have probably already heard of Centene (CNC) and Humana (HUM). But which of these two stocks presents investors with the better value opportunity right now?
The P/B ratio helps to identify low-priced stocks with high growth prospects. CNC, MD, PFE, STNE and SAN are some such stocks.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
CNC's Q1 results benefit from improved premiums as a result of a strong PDP business, partly offset by elevated operating costs. It currently expects 2025 premium and service revenues within $164-$166 billion.
Centene Corporation (NYSE:CNC ) Q1 2025 Earnings Conference Call April 25, 2025 8:30 AM ET Company Participants Jennifer Gilligan - Senior Vice President, Finance and Investor Relations Sarah London - Chief Executive Officer Andrew Asher - Executive Vice President and Chief Financial Officer Conference Call Participants Josh Raskin - Nefron Research A.J. Rice - UBS Justin Lake - Wolfe Research Ann Hynes - Mizuho Securities Stephen Baxter - Wells Fargo David Windley - Jefferies Sarah James - Cantor Fitzgerald Andrew Mok - Barclays Lance Wilkes - Bernstein John Stansel - JPMorgan Joaquin Arriagada - Bank of America George Hill - Deutsche Bank Ryan Langston - TD Cowen Michael Ha - Baird Operator Good day and welcome to the Centene Corporation First Quarter 2025 Conference Call.
The headline numbers for Centene (CNC) give insight into how the company performed in the quarter ended March 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Centene (CNC) came out with quarterly earnings of $2.90 per share, beating the Zacks Consensus Estimate of $2.36 per share. This compares to earnings of $2.26 per share a year ago.
CNC's first-quarter results are likely to benefit from higher commercial marketplace memberships.
Get a deeper insight into the potential performance of Centene (CNC) for the quarter ended March 2025 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.
Centene (CNC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
CNC's subsidiary, SilverSummit, secures a five-year Nevada Medicaid contract, reinforcing its foothold in managed care in rural and frontier areas.